This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Early Registration Savings Deadline Expires In:

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event from March 14-17, 2022
Attend In-Person or 100% Digitally!San Diego Convention Center, San Diego, California

Stephen Spagnol, PhD
Associate Director at Janssen R&D (pending final confirmation)


Stephen Spagnol received his B.S. in Chemical Engineering from Penn State in 2010, and went on to receive his Ph.D. in Chemical Engineering from Carnegie Mellon in 2015. He started his career at Merck & Co. in 2015 in Pharmaceutical Sciences. While at Merck, he led formulation and process development efforts in RNA therapeutics including vaccines and novel therapeutics in immuno-oncology. He also has extensive experience in the design and optimization of novel drug delivery technologies for RNA therapeutics. He recently joined Johnson & Johnson where he is a Senior Scientist in Large Molecule Drug Product Development.

Agenda Sessions

  • Development Strategies for AAV Gene Therapy


Speakers at this event